10 Jefferies Group PTC Therapeutics Trades
Jefferies Group's position in PTC Therapeutics is currently worth $96.1M. That's 1.11% of their equity portfolio (13th largest holding). The investor owns 1.63% of the outstanding PTC Therapeutics stock. The first PTC Therapeutics trade was made in Q1 2023. Since then Jefferies Group bought shares six more times and sold shares on three occasions. The stake costed the investor $71.7M, netting the investor a gain of 34% so far.
News about PTC Therapeutics Inc and Jefferies Group
Palo Alto Networks To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Thursday
Needham raised the price target for Dynatrace, Inc. (NYSE: DT ) from $52 to $56. Needham analyst James Ricchiuti maintained a Buy rating. Dynatrace shares ga...
PTC Therapeutics (NASDAQ:PTCT) Shares Gap Up on Analyst Upgrade
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) shares gapped up before the market opened on Friday after Credit Suisse Group raised their price target on ...
New Four-Year Data for Genentech''s Evrysdi Reinforce Long-Term Efficacy and Safety Profile in Some of the Most Severely Affected People With Types 2 and 3 Spinal Muscular Atrophy (SMA)
– Data from pivotal SUNFISH study showed increases in motor function observed during the first year were maintained through the fourth year, while the overal...